Tevogen Bio Holdings Inc. — Balance Sheet Charts
10 snapshots of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+4.8% +$204K
$4M
Current Assets↓-39.9% -$1M
$2M
Cash & Equivalents
$0
Net PPE↓-51.4% -$173K
$164K
Total Liabilities↑+17.5% +$2M
$12M
Current Liabilities↓-35.3% -$4M
$7M
Account Payables↓-43.3% -$3M
$3M
Short-Term Debt
—
Stockholders Equity↓-26.4% -$2M
$-8M
Retained Earnings↓-29.9% -$31M
$-135M
Operating Lease ROU Asset↑+397.9% +$1M
$1M
Operating Lease Liability↑+2602.7% +$1M
$1M
Gross PP&E↑+0.0% +$0
$722K
Accumulated Depreciation↑+61.6% +$162K
$425K